Taisuke Matsuo, Deceased

This inventor holds 6 USPTO granted patents. Top assignee: Takeda Chemical Industries, Inc.. Active years: 1985-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Taisuke Matsuo, Deceased. Retrieved from https://idiyas.com/inventor/taisuke-matsuo-deceased

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 3

Forward Citations = 26(Granted Patents)

Location History:

late of Osaka, JP (1985 - 1987)
late of Ibaraki, JP (1986 - 1988)

Company Filing History:

6 out of 1,858

Takeda Chemical Industries, Inc.

patents

Years Active: 1985-1988

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 4782147 - 1-sulfo-2-oxoazetidine derivatives and their production (1988-11-01),

2. 4684724 - 4-Cyano-2-azetidinones and production thereof (1987-08-04),

3. 4675397 - 1-sulfo-2-oxoazetidine derivatives and their production (1987-06-23),

4. 4673739 - 4-carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their (1987-06-16),

5. 4572801 - 4-Carbamoyloxymethyl-1-sulfo-2-oxoazetidine derivatives and their (1986-02-25),

6. 4560508 - 4-Cyano-2-azetidinones and production thereof (1985-12-24),

Title: Taisuke Matsuo: A Legacy of Innovation in Pharmaceutical Chemistry

Introduction

Taisuke Matsuo was a notable inventor in the field of pharmaceutical chemistry, known for his contributions to the development of antimicrobial agents and beta-lactamase inhibitors. His work has had a significant impact on drug development for both humans and domesticated animals. Matsuo was based in Ibaraki, Japan, and held a total of 6 patents during his career.

Latest Patents

Matsuo's latest patents include innovative compounds such as 1-sulfo-2-oxoazetidine derivatives and their production. These compounds are characterized by a general formula where R₁ can be an amino, acylated amino, or protected amino group, and exhibit antimicrobial and beta-lactamase-inhibitory activity. Another significant patent involves 4-cyano-2-azetidinones, which are useful as intermediates for synthesizing optically active 4-substituted-2-azetidinone derivatives. These compounds also serve as antimicrobial agents and beta-lactamase inhibitors.

Career Highlights

Matsuo worked at Takeda Chemical Industries, Inc., where he made substantial contributions to pharmaceutical research and development. His innovative work has paved the way for advancements in drug formulations and therapeutic applications.

Collaborations

Throughout his career, Matsuo collaborated with esteemed colleagues such as Michihiko Ochiai and Shoji Kishimoto. These collaborations fostered a productive environment for innovation and research in the pharmaceutical sector.

Conclusion

Taisuke Matsuo's legacy in pharmaceutical chemistry is marked by his innovative patents and collaborations that have significantly advanced the field. His contributions continue to influence drug development and therapeutic strategies today.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]